United States · FDA National Drug Code directory
Prochlorperazine Edisylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0713-0351_284f182c-9dde-805f-e063-6394a90a0f02
- Product NDC
- 0713-0351
- Form
- INJECTION
- Composition / generic term
- Prochlorperazine Edisylate
- Labeler
- Cosette Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220211
- Source listing expiry
- 20261231
Source-listed ingredients
- PROCHLORPERAZINE EDISYLATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 PACKAGE (0713-0351-09) / 2 mL in 1 VIAL (0713-0351-02) · 0713-0351-09
- 25 VIAL in 1 PACKAGE (0713-0351-25) / 2 mL in 1 VIAL (0713-0351-02) · 0713-0351-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →